| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.38 | 0.008 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.34 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.0003 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.2 | 2e-05 |